Hydroxychloroquine for Joint Pain in Breast Cancer
(AIMSS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate the effectiveness of hydroxychloroquine sulfate (a type of drug commonly used to treat joint pain caused by inflammation, swelling) in reducing joint pain associated with Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) for patients with breast cancer.
Who Is on the Research Team?
Tarah Ballinger, MD
Principal Investigator
IUSCCC
Are You a Good Fit for This Trial?
This trial is for people with breast cancer who are experiencing joint pain and stiffness caused by taking aromatase inhibitors. Participants should not have other conditions or reasons that would prevent them from safely joining the study.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Hydroxychloroquine Sulfate
Trial Overview
The study is testing whether hydroxychloroquine sulfate, a drug often used for arthritis, can help reduce joint pain in breast cancer patients suffering from musculoskeletal symptoms due to aromatase inhibitor therapy.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Hydroxychloroquine sulfate, 400 mg orally once daily
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
100 Voices of Hope
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.